protein

SARS-CoV-2 S Protein RBD (Biotinylated, Omicron, B.1.1.529, His-Avi)

HY-P74446

10 μg;50 μg;100 μg

240;665;1060 USD

SARS-CoV-2 S Protein RBD (Biotinylated, Omicron, B.1.1.529, His-Avi)

proteins

HEK293

10 μg;50 μg;100 μg

240;665;1060 USD

The SARS-Cov-2 S glycoprotein is a SARS-Cov-2 S glycoprotein. The amino acid sequence 1261-1267a.a of the SARS-Cov-2 S glycoprotein is transmembrane. The SARS-Cov-2 S glycoprotein is a highly glycosylated trimer, each of which consists of 1260 amino acids (residues 14-1273), divided into four structural domains: the n-terminal domain (NTD), the c-terminal domain (CTD, also known as the receptor-binding domain, RBD), and two subdomains (SD1 and SD2). SARS-CoV-2 S Protein RBD (Biotinylated, Omicron, B.1.1.529, His-Avi) is the recombinant Virus-derived SARS-CoV-2 S protein RBD, expressed by HEK293 , with C-Avi, C-His labeled tag. The total length of SARS-CoV-2 S Protein RBD (Biotinylated, Omicron, B.1.1.529, His-Avi) is 223 a.a., with molecular weight of ~36.08 kDa.

Virus

SARS-Cov-2 is a enveloped positive-sense single-stranded RNA virus that causes COVID-19. SARS-CoV-2 possesses four structural proteins, namely the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M), and nucleocapsid protein (N). The SARS-Cov-2 S glycoprotein is located on the exterior of the viral particle, giving the coronavirus its crown-like appearance. The SARS-Cov-2 S glycoprotein can mediate the attachment and entry of viral particles into host cells and is an important target for vaccine development, antibody therapy, and antigen-based diagnostic esting [1] [2] [3] [4] [5] .

SARS-CoV-2 RBD Protein; SARS-CoV-2 Spike RBD Protein; SARS-CoV-2 S Protein RBD

Greater than 95% as determined by reducing SDS-PAGE.

Supplied as a 0.2 μm filtered solution of PBS, pH 7.4.

Shipping with dry ice